Study of an oral drug for bipolar depression
Part of Mental health clinical trials.
This trial tests an experimental pill (ABB-932) for people with bipolar I or II disorder who are currently in a depressive episode. The goal is to see if the drug is safe and helps improve mood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and have a BMI between 18 and 40.
- You are currently having a depressive episode that has lasted at least 4 weeks but no more than 12 months.
- You have not been hospitalized for mental health reasons in the past 3 months.
- You have never had schizophrenia or other psychotic disorders.
- You have not had a moderate or severe substance use disorder (except nicotine) in the past 6 months.
- You do not have unstable medical conditions like severe kidney or liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the study drug azetukalner can help reduce depression symptoms in people with bipolar I or II disorder who are currently having a depressive episode. You would be randomly assigned to receive either the drug or a placebo (inactive pill) to see which works better.
This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.
This study tests an investigational drug called ABBV-932 in people with bipolar disorder. It looks at how the drug moves through the body when taken with another medication (itraconazole) and checks for any side effects.
This trial tests whether OSU6162 can improve depressive symptoms in adults with bipolar depression who are already taking a stable mood-stabilizing medicine. It also checks safety by closely monitoring mood, heart rhythm, and other health factors during the study.
This trial tests an investigational medication (NBI-1065845) added to your current antidepressant to see if it can improve depressive symptoms. It is for people with moderate to severe depression who have not fully responded to their current antidepressant.
This study tests an oral medication called icalcaprant for adults with bipolar I or II who are currently in a depressive episode. The goal is to see if it reduces symptoms and whether it's safe when taken alongside your usual mood stabilizer.
Hear when a new Bipolar I or II Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.